Growth Metrics

Strata Critical Medical (SRTA) Equity Ratio (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Equity Ratio for 7 consecutive years, with 0.86 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 0.84% to 0.86 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.86 through Dec 2025, down 0.84% year-over-year, with the annual reading at 0.86 for FY2025, 0.84% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.86 at Strata Critical Medical, up from 0.84 in the prior quarter.
  • The five-year high for Equity Ratio was 0.9 in Q2 2022, with the low at 0.03 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.81, with a median of 0.85 recorded in 2025.
  • The sharpest move saw Equity Ratio crashed 39.94% in 2021, then skyrocketed 3021.33% in 2022.
  • Over 5 years, Equity Ratio stood at 0.87 in 2021, then dropped by 2.65% to 0.84 in 2022, then decreased by 5.93% to 0.79 in 2023, then increased by 8.84% to 0.86 in 2024, then dropped by 0.84% to 0.86 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.86, 0.84, and 0.87 for Q4 2025, Q3 2025, and Q2 2025 respectively.